icobrain

🟢Active

icobrain is a portfolio of cloud-based medical imaging software from icometrix. It applies AI to brain CT and MRI scans to quantify abnormalities and support clinicians in neurological assessment and follow-up.

Why Abandoned

icometrix continues to present icobrain products on its website, and a 2024 company announcement describes expanded U.S. availability following FDA clearance for icobrain aria.

🩺 Health Signals

No checks have been run on this tool yet.

📅 Timeline

2011-01-01

icometrix founded

2019-05-16

Series A funding announced

2022-06-30

icobrain ms receives FDA Breakthrough Device designation

2024-02-01

icobrain aria receives FDA clearance

🔄 Alternatives to icobrain

🪦 Other dead Healthcare tools

Frequently Asked Questions

What is icobrain?

icobrain is icometrix’s portfolio of AI-assisted medical imaging software for analyzing brain CT and MRI scans. Different modules quantify findings relevant to conditions such as multiple sclerosis, dementia, traumatic brain injury, stroke, epilepsy, and treatment-related imaging abnormalities.

Who makes icobrain?

icobrain is developed by icometrix, a Belgian medical-technology company founded by Wim Van Hecke and Dirk Smeets.

How does icobrain analyze MRI and CT scans?

icobrain uses automated image-processing and machine-learning methods to segment brain structures or abnormalities, calculate quantitative measures, and generate reports intended to support radiologists and neurologists.

Is icobrain FDA cleared?

Regulatory status varies by module and intended use. icometrix reports FDA clearances for specific icobrain products, including icobrain aria; healthcare providers should verify the authorization and labeling applicable to their country and use case.

Is icobrain a replacement for a radiologist?

No. icobrain is clinical decision-support software intended to provide quantitative imaging information. Interpretation and patient-management decisions remain the responsibility of qualified healthcare professionals.